Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses
Covaxin/BBV152 is a whole virion inactivated SARS-CoV-2 vaccine. The effect of prime-boost vaccination with Covaxin on systemic immune responses is not known. We investigated the effect of Covaxin on the plasma levels of a wide panel of cytokines and chemokines at baseline (M0) and at months 1 (M1),...
Main Authors: | Nathella Pavan Kumar, V. V. Banurekha, Girish Kumar C. P., Arul Nancy, C. Padmapriyadarsini, A. Stella Mary, K. R. Uma Devi, Manoj Murhekar, Subash Babu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.752397/full |
Similar Items
-
Inactivated vaccine Covaxin/BBV152: A systematic review
by: Tousief Irshad Ahmed, et al.
Published: (2022-08-01) -
A Computational Approach for Molecular Characterization of Covaxin (BBV152) and Its Ingredients for Assessing Its Efficacy against COVID-19
by: Atala B. Jena, et al.
Published: (2022-08-01) -
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context
by: Mangaiarkarasi S. Asokan, et al.
Published: (2024-03-01) -
Post COVID vaccination (COVAXIN™ -BB152 V) pauci-immune crescentic glomerulonephritis
by: Shyam B Bansal, et al.
Published: (2022-01-01) -
“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
by: Sunil Kumar Raina, et al.
Published: (2021-01-01)